Academic Journal
Cross-Species Identification of Urinary Small Extracellular Vesicle-Associated miR-223-3p as a Candidate Biomarker for Nephrolithiasis in a Discovery Cohort.
| Τίτλος: | Cross-Species Identification of Urinary Small Extracellular Vesicle-Associated miR-223-3p as a Candidate Biomarker for Nephrolithiasis in a Discovery Cohort. |
|---|---|
| Συγγραφείς: | Chen BJ; Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan., Uk JJ; Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan., Shen CH; Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan., Fang CY; Department of Medical Research, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan., Lai YY; Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan., Hong YW; Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan., Eaw CY; Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan., Chuang MC; Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan., Chen JC; Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan. |
| Πηγή: | International journal of medical sciences [Int J Med Sci] 2026 Aug 24; Vol. 23 (10), pp. 3169-3182. Date of Electronic Publication: 2026 Aug 24 (Print Publication: 2026). |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101213954 Publication Model: eCollection Cited Medium: Internet ISSN: 1449-1907 (Electronic) Linking ISSN: 14491907 NLM ISO Abbreviation: Int J Med Sci Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: [Australia] : Ivyspring International Publisher, c2004- |
| Ιατρικοί όροι (MeSH): | MicroRNAs*/urine , MicroRNAs*/genetics , Nephrolithiasis*/urine , Nephrolithiasis*/genetics , Nephrolithiasis*/diagnosis , Nephrolithiasis*/pathology , Extracellular Vesicles*/genetics , Extracellular Vesicles*/metabolism, Biomarkers/urine ; Kidney/pathology ; Humans ; Animals ; Mice ; Female ; Male ; Disease Models, Animal ; Middle Aged ; Adult ; Gene Expression Profiling |
| Περίληψη: | Background: Nephrolithiasis remains a major global health burden with limited non-invasive tools for early diagnosis and monitoring. Urinary small extracellular vesicle (sEV)-associated microRNAs (miRNAs) are stable molecular signatures that reflect renal pathophysiological shifts. This study aims to identify candidate urinary sEV-associated miRNAs for nephrolithiasis in a clinical discovery cohort and prioritize candidate biomarkers by integrating human urinary sEV miRNA profiles with publicly available murine nephrolithiasis datasets. Methods: Small RNA sequencing was performed on RNA isolated from urinary sEVs obtained from a clinical discovery cohort (25 patients with nephrolithiasis and 8 healthy controls) to identify candidate biomarkers associated with nephrolithiasis. Differentially expressed miRNAs (DEmiRNAs) were identified using a |log₂ fold change| > 1 and adjusted P < 0.05 threshold. Functional enrichment (GO/KEGG) was conducted on predicted target genes. To prioritize biologically relevant candidates, human DEmiRNAs were intersected with an available murine kidney miRNA dataset (GSE186793) and the ExoCarta database. The lead candidate, miR-223-3p, was further validated via RT-qPCR in human urinary sEV samples and urinary sEVs isolated from an independent CaOx-induced mouse model. Results: We identified 111 significantly dysregulated urinary sEV-associated miRNAs (105 upregulated, 6 downregulated) in patients with nephrolithiasis. Functional analysis linked these miRNAs to endocytosis, mitochondrial organization, and the MAPK/Wnt signaling pathways. Integrative analysis of the human urinary sEV, the murine kidney miRNA datasets (GSE186793), and the ExoCarta database prioritized a conserved five-miRNA signature (miR-223-5p, miR-223-3p, miR-342-3p, let-7i-5p, and miR-29c-3p). Among these candidates, miR-223-3p demonstrated the strongest translational potential and was therefore selected for further validation. RT-qPCR confirmed that miR-223-3p was significantly upregulated in both human urinary sEVs and urinary sEVs from the CaOx-induced mouse model. Conclusion: Our findings characterize a distinct urinary sEVs-associated miRNA landscape within this discovery cohort and identify miR-223-3p as a promising candidate biomarker for nephrolithiasis. Given the relatively small, clinically heterogeneous discovery cohort and the absence of an independent validation cohort, these findings should be considered hypothesis-generating and require validation in larger, independent, clinically stratified prospective studies before clinical application. (© The author(s).) |
| Competing Interests: | Competing Interests: The authors declared that no know competing financial interests or personal relationships that could appeard to influence the work reported in this paper. |
| References: | Front Pharmacol. 2020 Jan 31;10:1655. (PMID: 32082158) Front Physiol. 2022 Aug 29;13:941143. (PMID: 36105281) Int J Mol Sci. 2025 Sep 05;26(17):. (PMID: 40943598) Biomed Pharmacother. 2024 Apr;173:116393. (PMID: 38461684) Shock. 2022 Mar 1;57(3):417-426. (PMID: 34710881) Biochim Biophys Acta Mol Cell Res. 2024 Jan;1871(1):119604. (PMID: 37806389) J Gerontol A Biol Sci Med Sci. 2024 Jul 1;79(7):. (PMID: 38447057) Nat Rev Nephrol. 2025 Nov;21(11):794-808. (PMID: 40790363) Oxid Med Cell Longev. 2021 Sep 2;2021:1676152. (PMID: 34512861) J Cell Physiol. 2019 May;234(5):5451-5465. (PMID: 30471116) Urology. 2022 Aug;166:104-110. (PMID: 35636636) Front Cell Dev Biol. 2020 Apr 15;8:244. (PMID: 32351960) Cell Mol Life Sci. 2024 Aug 25;81(1):369. (PMID: 39182194) Kidney360. 2023 Feb 1;4(2):245-257. (PMID: 36821616) J Proteomics. 2018 Aug 15;185:64-76. (PMID: 29953960) Inflamm Res. 2023 Mar;72(3):553-576. (PMID: 36640195) J Am Soc Nephrol. 2016 Jan;27(1):12-26. (PMID: 26251351) EBioMedicine. 2019 Jan;39:552-561. (PMID: 30467011) Ann Med Surg (Lond). 2024 Sep 10;86(10):5802-5810. (PMID: 39359758) Asian J Urol. 2018 Oct;5(4):205-214. (PMID: 30364478) Int J Biochem Cell Biol. 2022 Aug;149:106262. (PMID: 35787447) Int J Mol Sci. 2021 Jun 17;22(12):. (PMID: 34204452) Crit Rev Immunol. 2024;44(3):53-65. (PMID: 38421705) World J Urol. 2017 Sep;35(9):1301-1320. (PMID: 28213860) Nano Lett. 2023 Feb 22;23(4):1555-1563. (PMID: 36727669) Kaohsiung J Med Sci. 2024 Sep;40(9):789-800. (PMID: 39252576) J Cell Mol Med. 2019 Nov;23(11):7268-7278. (PMID: 31489770) Biochem Biophys Res Commun. 2023 Mar 12;648:50-58. (PMID: 36731227) Mol Biomed. 2025 Nov 17;6(1):110. (PMID: 41247622) |
| Contributed Indexing: | Keywords: Nephrolithiasis; Urinary small extracellular vesicle; biomarkers; microRNAs |
| Substance Nomenclature: | 0 (MicroRNAs) 0 (Biomarkers) 0 (MIR223, human) 0 (MIRN223 microRNA, mouse) |
| Entry Date(s): | Date Created: 20260929 Date Completed: 20260929 Latest Revision: 20260930 |
| Update Code: | 20260930 |
| PubMed Central ID: | PMC13617494 |
| DOI: | 10.7150/ijms.136918 |
| PMID: | 42807802 |
| Βάση Δεδομένων: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=14491907&ISBN=&volume=23&issue=10&date=20260824&spage=3169&pages=3169-3182&title=International journal of medical sciences&atitle=Cross-Species%20Identification%20of%20Urinary%20Small%20Extracellular%20Vesicle-Associated%20miR-223-3p%20as%20a%20Candidate%20Biomarker%20for%20Nephrolithiasis%20in%20a%20Discovery%20Cohort.&aulast=Chen%20BJ&id=DOI:10.7150/ijms.136918 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 42807802 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cross-Species Identification of Urinary Small Extracellular Vesicle-Associated miR-223-3p as a Candidate Biomarker for Nephrolithiasis in a Discovery Cohort. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chen+BJ%22">Chen BJ</searchLink>; Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan.<br /><searchLink fieldCode="AU" term="%22Uk+JJ%22">Uk JJ</searchLink>; Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan.<br /><searchLink fieldCode="AU" term="%22Shen+CH%22">Shen CH</searchLink>; Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan.<br /><searchLink fieldCode="AU" term="%22Fang+CY%22">Fang CY</searchLink>; Department of Medical Research, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lai+YY%22">Lai YY</searchLink>; Department of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 60002, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hong+YW%22">Hong YW</searchLink>; Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan.<br /><searchLink fieldCode="AU" term="%22Eaw+CY%22">Eaw CY</searchLink>; Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chuang+MC%22">Chuang MC</searchLink>; Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+JC%22">Chen JC</searchLink>; Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101213954%22">International journal of medical sciences</searchLink> [Int J Med Sci] 2026 Aug 24; Vol. 23 (10), pp. 3169-3182. <i>Date of Electronic Publication: </i>2026 Aug 24 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101213954 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1449-1907 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214491907%22">14491907 </searchLink><i>NLM ISO Abbreviation: </i>Int J Med Sci <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Original Publication</i>: [Australia] : Ivyspring International Publisher, c2004- – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22MicroRNAs%22">MicroRNAs*</searchLink>/<searchLink fieldCode="MM" term="%22MicroRNAs+urine%22">urine</searchLink> <br /><searchLink fieldCode="MM" term="%22MicroRNAs%22">MicroRNAs*</searchLink>/<searchLink fieldCode="MM" term="%22MicroRNAs+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Nephrolithiasis%22">Nephrolithiasis*</searchLink>/<searchLink fieldCode="MM" term="%22Nephrolithiasis+urine%22">urine</searchLink> <br /><searchLink fieldCode="MM" term="%22Nephrolithiasis%22">Nephrolithiasis*</searchLink>/<searchLink fieldCode="MM" term="%22Nephrolithiasis+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Nephrolithiasis%22">Nephrolithiasis*</searchLink>/<searchLink fieldCode="MM" term="%22Nephrolithiasis+diagnosis%22">diagnosis</searchLink> <br /><searchLink fieldCode="MM" term="%22Nephrolithiasis%22">Nephrolithiasis*</searchLink>/<searchLink fieldCode="MM" term="%22Nephrolithiasis+pathology%22">pathology</searchLink> <br /><searchLink fieldCode="MM" term="%22Extracellular+Vesicles%22">Extracellular Vesicles*</searchLink>/<searchLink fieldCode="MM" term="%22Extracellular+Vesicles+genetics%22">genetics</searchLink> <br /><searchLink fieldCode="MM" term="%22Extracellular+Vesicles%22">Extracellular Vesicles*</searchLink>/<searchLink fieldCode="MM" term="%22Extracellular+Vesicles+metabolism%22">metabolism</searchLink><br /><searchLink fieldCode="MH" term="%22Biomarkers%22">Biomarkers</searchLink>/<searchLink fieldCode="MH" term="%22Biomarkers+urine%22">urine</searchLink> ; <searchLink fieldCode="MH" term="%22Kidney%22">Kidney</searchLink>/<searchLink fieldCode="MH" term="%22Kidney+pathology%22">pathology</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Animals%22">Animals</searchLink> ; <searchLink fieldCode="MH" term="%22Mice%22">Mice</searchLink> ; <searchLink fieldCode="MH" term="%22Female%22">Female</searchLink> ; <searchLink fieldCode="MH" term="%22Male%22">Male</searchLink> ; <searchLink fieldCode="MH" term="%22Disease+Models%2C+Animal%22">Disease Models, Animal</searchLink> ; <searchLink fieldCode="MH" term="%22Middle+Aged%22">Middle Aged</searchLink> ; <searchLink fieldCode="MH" term="%22Adult%22">Adult</searchLink> ; <searchLink fieldCode="MH" term="%22Gene+Expression+Profiling%22">Gene Expression Profiling</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background: Nephrolithiasis remains a major global health burden with limited non-invasive tools for early diagnosis and monitoring. Urinary small extracellular vesicle (sEV)-associated microRNAs (miRNAs) are stable molecular signatures that reflect renal pathophysiological shifts. This study aims to identify candidate urinary sEV-associated miRNAs for nephrolithiasis in a clinical discovery cohort and prioritize candidate biomarkers by integrating human urinary sEV miRNA profiles with publicly available murine nephrolithiasis datasets.<br />Methods: Small RNA sequencing was performed on RNA isolated from urinary sEVs obtained from a clinical discovery cohort (25 patients with nephrolithiasis and 8 healthy controls) to identify candidate biomarkers associated with nephrolithiasis. Differentially expressed miRNAs (DEmiRNAs) were identified using a |log₂ fold change| > 1 and adjusted P &lt; 0.05 threshold. Functional enrichment (GO/KEGG) was conducted on predicted target genes. To prioritize biologically relevant candidates, human DEmiRNAs were intersected with an available murine kidney miRNA dataset (GSE186793) and the ExoCarta database. The lead candidate, miR-223-3p, was further validated via RT-qPCR in human urinary sEV samples and urinary sEVs isolated from an independent CaOx-induced mouse model.<br />Results: We identified 111 significantly dysregulated urinary sEV-associated miRNAs (105 upregulated, 6 downregulated) in patients with nephrolithiasis. Functional analysis linked these miRNAs to endocytosis, mitochondrial organization, and the MAPK/Wnt signaling pathways. Integrative analysis of the human urinary sEV, the murine kidney miRNA datasets (GSE186793), and the ExoCarta database prioritized a conserved five-miRNA signature (miR-223-5p, miR-223-3p, miR-342-3p, let-7i-5p, and miR-29c-3p). Among these candidates, miR-223-3p demonstrated the strongest translational potential and was therefore selected for further validation. RT-qPCR confirmed that miR-223-3p was significantly upregulated in both human urinary sEVs and urinary sEVs from the CaOx-induced mouse model.<br />Conclusion: Our findings characterize a distinct urinary sEVs-associated miRNA landscape within this discovery cohort and identify miR-223-3p as a promising candidate biomarker for nephrolithiasis. Given the relatively small, clinically heterogeneous discovery cohort and the absence of an independent validation cohort, these findings should be considered hypothesis-generating and require validation in larger, independent, clinically stratified prospective studies before clinical application.<br /> (© The author(s).) – Name: Abstract Label: Competing Interests Group: Ab Data: Competing Interests: The authors declared that no know competing financial interests or personal relationships that could appeard to influence the work reported in this paper. – Name: Ref Label: References Group: RefInfo Data: Front Pharmacol. 2020 Jan 31;10:1655. (PMID: <searchLink fieldCode="PM" term="%2232082158%22">32082158)</searchLink><br />Front Physiol. 2022 Aug 29;13:941143. (PMID: <searchLink fieldCode="PM" term="%2236105281%22">36105281)</searchLink><br />Int J Mol Sci. 2025 Sep 05;26(17):. (PMID: <searchLink fieldCode="PM" term="%2240943598%22">40943598)</searchLink><br />Biomed Pharmacother. 2024 Apr;173:116393. (PMID: <searchLink fieldCode="PM" term="%2238461684%22">38461684)</searchLink><br />Shock. 2022 Mar 1;57(3):417-426. (PMID: <searchLink fieldCode="PM" term="%2234710881%22">34710881)</searchLink><br />Biochim Biophys Acta Mol Cell Res. 2024 Jan;1871(1):119604. (PMID: <searchLink fieldCode="PM" term="%2237806389%22">37806389)</searchLink><br />J Gerontol A Biol Sci Med Sci. 2024 Jul 1;79(7):. (PMID: <searchLink fieldCode="PM" term="%2238447057%22">38447057)</searchLink><br />Nat Rev Nephrol. 2025 Nov;21(11):794-808. (PMID: <searchLink fieldCode="PM" term="%2240790363%22">40790363)</searchLink><br />Oxid Med Cell Longev. 2021 Sep 2;2021:1676152. (PMID: <searchLink fieldCode="PM" term="%2234512861%22">34512861)</searchLink><br />J Cell Physiol. 2019 May;234(5):5451-5465. (PMID: <searchLink fieldCode="PM" term="%2230471116%22">30471116)</searchLink><br />Urology. 2022 Aug;166:104-110. (PMID: <searchLink fieldCode="PM" term="%2235636636%22">35636636)</searchLink><br />Front Cell Dev Biol. 2020 Apr 15;8:244. (PMID: <searchLink fieldCode="PM" term="%2232351960%22">32351960)</searchLink><br />Cell Mol Life Sci. 2024 Aug 25;81(1):369. (PMID: <searchLink fieldCode="PM" term="%2239182194%22">39182194)</searchLink><br />Kidney360. 2023 Feb 1;4(2):245-257. (PMID: <searchLink fieldCode="PM" term="%2236821616%22">36821616)</searchLink><br />J Proteomics. 2018 Aug 15;185:64-76. (PMID: <searchLink fieldCode="PM" term="%2229953960%22">29953960)</searchLink><br />Inflamm Res. 2023 Mar;72(3):553-576. (PMID: <searchLink fieldCode="PM" term="%2236640195%22">36640195)</searchLink><br />J Am Soc Nephrol. 2016 Jan;27(1):12-26. (PMID: <searchLink fieldCode="PM" term="%2226251351%22">26251351)</searchLink><br />EBioMedicine. 2019 Jan;39:552-561. (PMID: <searchLink fieldCode="PM" term="%2230467011%22">30467011)</searchLink><br />Ann Med Surg (Lond). 2024 Sep 10;86(10):5802-5810. (PMID: <searchLink fieldCode="PM" term="%2239359758%22">39359758)</searchLink><br />Asian J Urol. 2018 Oct;5(4):205-214. (PMID: <searchLink fieldCode="PM" term="%2230364478%22">30364478)</searchLink><br />Int J Biochem Cell Biol. 2022 Aug;149:106262. (PMID: <searchLink fieldCode="PM" term="%2235787447%22">35787447)</searchLink><br />Int J Mol Sci. 2021 Jun 17;22(12):. (PMID: <searchLink fieldCode="PM" term="%2234204452%22">34204452)</searchLink><br />Crit Rev Immunol. 2024;44(3):53-65. (PMID: <searchLink fieldCode="PM" term="%2238421705%22">38421705)</searchLink><br />World J Urol. 2017 Sep;35(9):1301-1320. (PMID: <searchLink fieldCode="PM" term="%2228213860%22">28213860)</searchLink><br />Nano Lett. 2023 Feb 22;23(4):1555-1563. (PMID: <searchLink fieldCode="PM" term="%2236727669%22">36727669)</searchLink><br />Kaohsiung J Med Sci. 2024 Sep;40(9):789-800. (PMID: <searchLink fieldCode="PM" term="%2239252576%22">39252576)</searchLink><br />J Cell Mol Med. 2019 Nov;23(11):7268-7278. (PMID: <searchLink fieldCode="PM" term="%2231489770%22">31489770)</searchLink><br />Biochem Biophys Res Commun. 2023 Mar 12;648:50-58. (PMID: <searchLink fieldCode="PM" term="%2236731227%22">36731227)</searchLink><br />Mol Biomed. 2025 Nov 17;6(1):110. (PMID: <searchLink fieldCode="PM" term="%2241247622%22">41247622)</searchLink> – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>Nephrolithiasis; Urinary small extracellular vesicle; biomarkers; microRNAs – Name: NumberCAS Label: Substance Nomenclature Group: ID Data: 0 (MicroRNAs)<br />0 (Biomarkers)<br />0 (MIR223, human)<br />0 (MIRN223 microRNA, mouse) – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260929 <i>Date Completed: </i>20260929 <i>Latest Revision: </i>20260930 – Name: DateUpdate Label: Update Code Group: Date Data: 20260930 – Name: PubmedCentralID Label: PubMed Central ID Group: ID Data: PMC13617494 – Name: DOI Label: DOI Group: ID Data: 10.7150/ijms.136918 – Name: AN Label: PMID Group: ID Data: 42807802 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=42807802 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7150/ijms.136918 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3169 Subjects: – SubjectFull: Biomarkers urine Type: general – SubjectFull: Kidney pathology Type: general – SubjectFull: Humans Type: general – SubjectFull: Animals Type: general – SubjectFull: Mice Type: general – SubjectFull: Female Type: general – SubjectFull: Male Type: general – SubjectFull: Disease Models, Animal Type: general – SubjectFull: Middle Aged Type: general – SubjectFull: Adult Type: general – SubjectFull: Gene Expression Profiling Type: general – SubjectFull: MicroRNAs urine Type: general – SubjectFull: MicroRNAs genetics Type: general – SubjectFull: Nephrolithiasis urine Type: general – SubjectFull: Nephrolithiasis genetics Type: general – SubjectFull: Nephrolithiasis diagnosis Type: general – SubjectFull: Nephrolithiasis pathology Type: general – SubjectFull: Extracellular Vesicles genetics Type: general – SubjectFull: Extracellular Vesicles metabolism Type: general Titles: – TitleFull: Cross-Species Identification of Urinary Small Extracellular Vesicle-Associated miR-223-3p as a Candidate Biomarker for Nephrolithiasis in a Discovery Cohort. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen BJ – PersonEntity: Name: NameFull: Uk JJ – PersonEntity: Name: NameFull: Shen CH – PersonEntity: Name: NameFull: Fang CY – PersonEntity: Name: NameFull: Lai YY – PersonEntity: Name: NameFull: Hong YW – PersonEntity: Name: NameFull: Eaw CY – PersonEntity: Name: NameFull: Chuang MC – PersonEntity: Name: NameFull: Chen JC IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 08 Text: 2026 Aug 24 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1449-1907 Numbering: – Type: volume Value: 23 – Type: issue Value: 10 Titles: – TitleFull: International journal of medical sciences Type: main |
| ResultId | 1 |